Adrenergic drugs for urinary incontinence in adults.
Explore this paper's citation graph
Summary
The limited evidence suggested that an adrenergic agonist drug is better than placebo in reducing number of pad changes and incontinence episodes, as well as improvement in subjective symptoms.
- Type
- review
- Published
- 2005-07-20
- Cited by
- 103
- References
- 38
- Access
- Open access
- OpenAlex
- https://openalex.org/W1871197842
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:30272194
Keywords
Medicine, Urinary incontinence, Placebo, Phenylpropanolamine, Adrenergic
References
- Mazindol in the control of micturition.
- The effect of phenylpropanolamine on female stress urinary incontinence.
- Sensory urgency in females: treatment with phenylpropanolamine.
- Alpha 1-adrenoceptor subtypes in the human cardiovascular and urogenital systems.
- Oral and intravaginal estrogens alone and in combination with alpha-adrenergic stimulation in genuine stress incontinence
- α1L‐Adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man
- Pelvic Muscle Exercise for Stress Urinary Incontinence in Elderly Women
- A double-blind clinical trial of a β2-adrenergic agonist in stress incontinence
- Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence.
- Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride
- Phenylpropanolamine in treatment of female stress urinary incontinence. Double-blind placebo controlled study in 24 patients.
- Norfenefrine in the treatment of female stress incontinence. A double-blind controlled trial.
- Acute effect of norfenefrine on the urethral pressure profile in females with genuine stress incontinence.
- Evaluation of Current Urodynamic Testing Methods in the Diagnosis of Genuine Stress Incontinence
- Effect of methoxamine on maximum urethral pressure in women with genuine stress incontinence: A placebo‐controlled, double‐blind crossover study
- Stress urinary incontinence in postmenopausal women treated with oral estrogen (estriol) and an alpha-adrenoceptor-stimulating agent (phenylpropanolamine): A randomized double-blind placebo-controlled study
- Radical retropubic prostatectomy for localised prostatic carcinoma: a clinical and pathological study of 201 cases.
- Prevalence of urinary incontinence.
- Urethral sphincteric insufficiency in postmenopausal females: treatment with phenylpropanolamine and estriol separately and in combination. A urodynamic and clinical evaluation.
- Lack of effect of cholinergic blocking and alpha-adrenergic stimulation on nocturnal incontinence after ileocaecal bladder replacement. A controlled randomised study.
Cited by
- Postprostatectomy established stress urinary incontinence treated with duloxetine.
- Guideline of guidelines: urinary incontinence
- Anatomy and histology of the lower urinary tract.
- Clinical management of urinary incontinence in women.
- Dysfunction of lower urinary tract in patients with spinal cord injury.
- Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women.
- Le traitement conservateur de l’incontinence urinaire d’effort de la femme
- Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
- Mid-urethral sling operations for stress urinary incontinence in women.
- Absorbent products for light urinary incontinence in women.
- Urodynamic investigations for management of urinary incontinence in children and adults
- Urodynamic studies for management of urinary incontinence in children and adults.
- Oestrogen therapy for urinary incontinence in post-menopausal women.
- Mechanical devices for urinary incontinence in women.
- Medical management of stress urinary incontinence: Is there a future?
- An update on the pharmacotherapy for lower urinary tract dysfunction
- Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance.
- [Guidelines for the medical treatment of non-neurological urinary incontinence in women].
- α1-Adrenoceptors as potential therapeutic targets
- Emerging treatments for urinary incontinence
Related papers
- Neurologic complications of phenylpropanolamine use.
- Phenylpropanolamine: A review
- Phenylpropanolamine increases plasma caffeine levels
- Three controlled trials of weight loss with phenylpropanolamine.
- Treatment of clozapine-induced weight gain with phenylpropanolamine
- The safety of phenylpropanolamine in patients with stable hypertension.
- A double dose of phenylpropanolamine causes transient hypertension.
- Comparative brain levels of phenylpropanolamine and amphetamine in rats.
- Effects of ephedrine and phenylpropanolamine on the antinociceptive effects of morphine and codeine in mice.